Literature DB >> 16435201

Pulmonary hypertension--a new manifestation of mitochondrial disease.

A R Barclay1, G Sholler, J Christodolou, A Shun, S Arbuckle, S Dorney, M O Stormon.   

Abstract

Mitochondrial respiratory chain (RC) abnormalities in children can present as multiorgan disease, including liver failure, usually within the first year of life. Cardiorespiratory complications have previously been described in association with RC defects; however, to our knowledge no cases of pulmonary hypertension have been described. We discuss two patients with proven mitochondrial RC liver disease who developed severe pulmonary hypertension, one subsequent to cadaveric orthotopic liver transplantation, the second in the neonatal period. It is our contention that pulmonary hypertension should now be included as another potential manifestation of paediatric mitochondrial disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16435201     DOI: 10.1007/s10545-005-4484-x

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  38 in total

1.  Severe portopulmonary hypertension after liver transplantation in a patient with preexisting hepatopulmonary syndrome.

Authors:  G Martinez-Pallí; J A Barberà; P Taurà; I Cirera; J Visa; R Rodriguez-Roisin
Journal:  J Hepatol       Date:  1999-12       Impact factor: 25.083

Review 2.  Pulmonary arterial hypertension.

Authors:  Harrison W Farber; Joseph Loscalzo
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

Review 3.  Mitochondria and childhood liver diseases.

Authors:  R J Sokol; W R Treem
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-01       Impact factor: 2.839

4.  Severe pulmonary hypertension and amelioration of hepatopulmonary syndrome after liver transplantation.

Authors:  M D Kaspar; M A Ramsay; C B Shuey; M F Levy; G G Klintmalm
Journal:  Liver Transpl Surg       Date:  1998-03

5.  Mitochondrial electron transport chain defect presenting as hypoglycemia.

Authors:  M L Freckmann; D R Thorburn; D M Kirby; K R Kamath; J Hammond; X Dennett; J Christodoulou
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

Review 6.  Investigation of mitochondrial disease.

Authors:  J Poulton; G K Brown
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

7.  Progressive plexogenic pulmonary hypertension following liver transplantation.

Authors:  M S Mandell; B M Groves; J Duke
Journal:  Transplantation       Date:  1995-05-27       Impact factor: 4.939

8.  Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests.

Authors:  R N Channick; J W Newhart; F W Johnson; P J Williams; W R Auger; P F Fedullo; K M Moser
Journal:  Chest       Date:  1996-06       Impact factor: 9.410

Review 9.  Epidemiology and treatment of mitochondrial disorders.

Authors:  P F Chinnery; D M Turnbull
Journal:  Am J Med Genet       Date:  2001

Review 10.  Primary pulmonary hypertension.

Authors:  James R Runo; James E Loyd
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

View more
  11 in total

1.  Mitochondrial respiratory chain hepatopathies: role of liver transplantation. A case series of five patients.

Authors:  Elisabeth De Greef; John Christodoulou; Ian E Alexander; Albert Shun; Edward V O'Loughlin; David R Thorburn; Vicki Jermyn; Michael O Stormon
Journal:  JIMD Rep       Date:  2011-11-04

2.  BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.

Authors:  Qiujun Yu; Yi-Yin Tai; Ying Tang; Jingsi Zhao; Vinny Negi; Miranda K Culley; Jyotsna Pilli; Wei Sun; Karin Brugger; Johannes Mayr; Rajeev Saggar; Rajan Saggar; W Dean Wallace; David J Ross; Aaron B Waxman; Stacy G Wendell; Steven J Mullett; John Sembrat; Mauricio Rojas; Omar F Khan; James E Dahlman; Masataka Sugahara; Nobuyuki Kagiyama; Taijyu Satoh; Manling Zhang; Ning Feng; John Gorcsan; Sara O Vargas; Kathleen J Haley; Rahul Kumar; Brian B Graham; Robert Langer; Daniel G Anderson; Bing Wang; Sruti Shiva; Thomas Bertero; Stephen Y Chan
Journal:  Circulation       Date:  2019-05-07       Impact factor: 29.690

3.  Infantile cardiomyopathy caused by the T14709C mutation in the mitochondrial tRNA glutamic acid gene.

Authors:  Johan L K Van Hove; Cynthia Freehauf; Shelley Miyamoto; Georgirene D Vladutiu; Jacklyn Pancrudo; Eduardo Bonilla; Mark A Lovell; Gary W Mierau; Janet A Thomas; Sara Shanske
Journal:  Eur J Pediatr       Date:  2007-09-22       Impact factor: 3.183

Review 4.  Reactive oxygen species in pulmonary vascular remodeling.

Authors:  Saurabh Aggarwal; Christine M Gross; Shruti Sharma; Jeffrey R Fineman; Stephen M Black
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

5.  Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA((Leu)) gene (m.3243A>G).

Authors:  D M Sproule; J Dyme; J Coku; D de Vinck; E Rosenzweig; W K Chung; D C De Vivo
Journal:  J Inherit Metab Dis       Date:  2008-01-07       Impact factor: 4.982

6.  Genetic and hypoxic alterations of the microRNA-210-ISCU1/2 axis promote iron-sulfur deficiency and pulmonary hypertension.

Authors:  Kevin White; Yu Lu; Sofia Annis; Andrew E Hale; B Nelson Chau; James E Dahlman; Craig Hemann; Alexander R Opotowsky; Sara O Vargas; Ivan Rosas; Mark A Perrella; Juan C Osorio; Kathleen J Haley; Brian B Graham; Rahul Kumar; Rajan Saggar; Rajeev Saggar; W Dean Wallace; David J Ross; Omar F Khan; Andrew Bader; Bernadette R Gochuico; Majed Matar; Kevin Polach; Nicolai M Johannessen; Haydn M Prosser; Daniel G Anderson; Robert Langer; Jay L Zweier; Laurence A Bindoff; David Systrom; Aaron B Waxman; Richard C Jin; Stephen Y Chan
Journal:  EMBO Mol Med       Date:  2015-06       Impact factor: 12.137

7.  Recurrent inhibition of mitochondrial complex III induces chronic pulmonary vasoconstriction and glycolytic switch in the rat lung.

Authors:  Olga Rafikova; Anup Srivastava; Ankit A Desai; Ruslan Rafikov; Stevan P Tofovic
Journal:  Respir Res       Date:  2018-04-23

8.  Congenital lactic acidosis, cerebral cysts and pulmonary hypertension in an infant with FOXRED1 related complex I deficiency.

Authors:  Delia Apatean; Bojana Rakic; Catherine Brunel-Guitton; Glenda Hendson; Renkui Bai; Michael A Sargent; Pascal M Lavoie; Millan Patel; Sylvia Stockler-Ipsiroglu
Journal:  Mol Genet Metab Rep       Date:  2019-01-18

9.  Primary pulmonary hypertension as a manifestation of adult multi-system mitochondrial disorder.

Authors:  Josef Finsterer
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

10.  Mitochondrial Haplogroups and Risk of Pulmonary Arterial Hypertension.

Authors:  Samar Farha; Bo Hu; Suzy Comhair; Joe Zein; Raed Dweik; Serpil C Erzurum; Micheala A Aldred
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.